RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy vs chemo: new hope for bladder cancer patients?
Disease control Recruiting nowThis phase II trial compares two treatments for high-grade T1 bladder cancer that hasn't spread. One group gets the immunotherapy drug pembrolizumab plus radiation, while the other gets standard chemotherapy (cisplatin, gemcitabine, 5-fluorouracil, or mitomycin-C) plus radiation.…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Could a prostate drug help fight bladder cancer?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether bicalutamide, a drug typically used for prostate cancer, can change a protein linked to bladder cancer growth. Researchers will compare men with non-muscle invasive bladder cancer who take the drug to those who don't. The goal is to see i…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC